IZOBLOK Valuation
Is IZB undervalued compared to its fair value, analyst forecasts and its price relative to the market?
Valuation Score
4/6Valuation Score 4/6
Unter dem Marktwert
Deutlich unter dem Marktwert
Price-To-Earnings gegen Gleichaltrige
Price-To-Earnings gegen Industrie
PM vs. Fair Ratio
Analysten-Prognose
Share Price vs Fair Value
What is the Fair Price of IZB when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.
Unter dem Marktwert: IZB (PLN41.6) wird unter unserer Schätzung des Fair Value (PLN89.38) gehandelt.
Deutlich unter dem Marktwert: IZB wird um mehr als 20 % unter dem Marktwert gehandelt.
Key Valuation Metric
Which metric is best to use when looking at relative valuation for IZB?
Other financial metrics that can be useful for relative valuation.
| What is IZB's n/a Ratio? | |
|---|---|
| n/a | 0x |
| n/a | n/a |
| Market Cap | zł67.15m |
| Key Statistics | |
|---|---|
| Enterprise Value/Revenue | 0.5x |
| Enterprise Value/EBITDA | 5.4x |
| PEG Ratio | n/a |
Price to Earnings Ratio vs Peers
How does IZB's PE Ratio compare to its peers?
| Company | Forward PE | Estimated Growth | Market Cap |
|---|---|---|---|
| Peer Average | 11.5x | ||
ERG ERG Spólka Akcyjna | 10.9x | n/a | zł39.9m |
ORL Orzel Spolka Akcyjna | 14x | n/a | zł33.5m |
PCX PCC Exol | 11.8x | n/a | zł498.9m |
SEL Selena FM | 9.4x | n/a | zł742.2m |
IZB IZOBLOK | 4.8x | n/a | zł67.2m |
Price-To-Earnings gegen Gleichaltrige: IZB ist ein guter Wert, wenn man sein Price-To-Earnings Verhältnis (10.6x) mit dem Durchschnitt der anderen Unternehmen (10.6x) vergleicht.
Price to Earnings Ratio vs Industry
How does IZB's PE Ratio compare vs other companies in the European Chemicals Industry?
Price-To-Earnings gegen Industrie: IZB ist aufgrund seines Price-To-Earnings Verhältnisses (4.1x) im Vergleich zum European Chemicals Branchendurchschnitt (12.5x) ein guter Wert.
Price to Earnings Ratio vs Fair Ratio
What is IZB's PE Ratio compared to its Fair PE Ratio? This is the expected PE Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.
| Fair Ratio | |
|---|---|
| Current PE Ratio | 4.8x |
| Fair PE Ratio | n/a |
PM vs. Fair Ratio: Unzureichende Daten zur Berechnung der Price-To-Earnings Fair Ratio von IZB für die Bewertungsanalyse.
Analyst Price Targets
What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?
Analysten-Prognose: Unzureichende Daten für eine Preisprognose.